Medindia LOGIN REGISTER
Medindia
Advertisement

MDS Pharma Services Upgrades, Expands Singapore Global Central Laboratory Operation

Friday, October 17, 2008 General News
Advertisement
New facility creates greater efficiencies to better meet client needs



KING OF PRUSSIA, PA, Oct. 16 /PRNewswire-FirstCall/ - MDS Pharma Services, a leading provider of innovative drug-discovery and development solutions, today announced it has moved its Singapore Global Central Lab operation to a new, larger facility, enabling the contract research organization to better meet the current and emerging needs of its clients in the Asia-Pacific region.
Advertisement

Thanks to optimized layout and workflow, the new facility, which is located in the Marsiling Industrial Park, has twice its previous capacity for sample storage, processing, and safety testing. Increased capacity was required to handle both current sample volumes - MDS Pharma Services has seen its sample volume in Singapore double in the past year - and to meet anticipated increases in business as a result of growing research investment in the area.
Advertisement

"MDS Pharma Services has long recognized the importance of investing in the Asia-Pacific region, and our move to a new laboratory facility in Singapore - which is becoming a hub of drug-development activity - is a testament to our commitment to growing across Asia," says MDS Pharma Services President David Spaight. "We were the first Western contract research organization to own a facility in China, and the first clinical laboratory there to receive accreditation from the College of American Pathologists (CAP). MDS Pharma Services remains at the forefront of the industry with the resources, expertise and commitment to deliver Quality On-Time(TM) services for clients in Singapore and the entire Asia-Pacific region."

The Singapore central lab has earned National Glycohemoglobin Standardization Program (NGSP) Level 1 accreditation, which allows it to handle diabetes studies conducted under strict international guidelines. It has also earned CAP accreditation, and recently passed its CAP inspection with zero deficiencies.

The move further solidifies MDS Pharma Services presence in the Asia-Pacific region, an area with increasing importance in the drug-development industry. Since entering the region over a decade ago, MDS Pharma Services has built a strong staff of clinical development professionals with expertise in many areas. In addition to central lab services, the Singapore facility is one of its two Asia-Pacific sites - the other is Beijing, China - through which MDS Pharma Services offers its industry-leading integrated centralized cardiac safety services to the entire region. Singapore is also one of MDS Pharma Services' eight Asian Global Clinical Development sites that offer late-stage clinical trial monitoring. MDS Pharma Services offers pharmacology services from its Taipei, Taiwan location.

MDS Pharma Services provides central laboratory services in key geographic areas around the world, including Singapore, China, Canada, the United States, France and Germany.



About MDS Pharma Services



MDS Pharma Services is committed to delivering quality service on time. We offer a full spectrum of resources to meet the drug discovery and development needs of the pharmaceutical and biotechnology industries. With numerous facilities strategically located around the world, we apply advanced scientific and technological expertise throughout the drug discovery and development process - from lead optimization, pre-IND research, early clinical research (bioequivalence, phases I-IIa) and bioanalysis through to global clinical development (phases IIb-IV), central lab and centralized cardiac services. For more information, visit our website at www.mdsps.com.

MDS Pharma Services is a business unit of MDS Inc. (TSX: MDS; NYSE: MDZ), a global life sciences company that provides market-leading products and services that our customers need for the development of drugs and diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS has more than 5,500 highly skilled people in 29 countries. Find out more at www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.



SOURCE MDS Inc.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close